Agilent Technologies, Inc. (NYSE:A) Shares Bought by Wesbanco Bank Inc.

Wesbanco Bank Inc. raised its position in shares of Agilent Technologies, Inc. (NYSE:A) by 8.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,455 shares of the medical research company’s stock after purchasing an additional 190 shares during the quarter. Wesbanco Bank Inc.’s holdings in Agilent Technologies were worth $365,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the company. Crewe Advisors LLC boosted its position in Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after buying an additional 101 shares during the last quarter. Ridgewood Investments LLC purchased a new stake in shares of Agilent Technologies in the 2nd quarter valued at $29,000. Rise Advisors LLC increased its stake in shares of Agilent Technologies by 527.8% in the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after acquiring an additional 190 shares during the period. Riverview Trust Co purchased a new position in shares of Agilent Technologies during the first quarter worth $41,000. Finally, Larson Financial Group LLC lifted its position in Agilent Technologies by 29,300.0% during the first quarter. Larson Financial Group LLC now owns 294 shares of the medical research company’s stock valued at $43,000 after purchasing an additional 293 shares during the period. 87.42% of the stock is owned by institutional investors and hedge funds.

Agilent Technologies Stock Performance

NYSE A opened at $139.10 on Thursday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. Agilent Technologies, Inc. has a 1-year low of $96.80 and a 1-year high of $155.35. The company has a market cap of $40.58 billion, a PE ratio of 32.88, a price-to-earnings-growth ratio of 6.96 and a beta of 1.05. The stock’s 50 day simple moving average is $140.97 and its 200-day simple moving average is $138.86.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The company’s revenue for the quarter was down 5.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.43 earnings per share. As a group, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st will be paid a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a yield of 0.68%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is 22.22%.

Analyst Ratings Changes

A number of research firms have weighed in on A. Barclays lifted their price objective on Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a research note on Tuesday. Evercore ISI boosted their price target on Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. Stifel Nicolaus restated a “buy” rating and issued a $151.00 price objective on shares of Agilent Technologies in a research report on Monday, August 26th. Citigroup lifted their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Finally, Wolfe Research downgraded shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a report on Thursday, June 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $144.36.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction on Friday, July 26th. The stock was sold at an average price of $140.00, for a total value of $274,120.00. Following the completion of the sale, the chief executive officer now directly owns 26,076 shares of the company’s stock, valued at $3,650,640. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at approximately $5,801,595. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction on Friday, July 26th. The stock was sold at an average price of $140.00, for a total value of $274,120.00. Following the sale, the chief executive officer now directly owns 26,076 shares of the company’s stock, valued at approximately $3,650,640. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,953 shares of company stock worth $2,013,630 in the last ninety days. Insiders own 0.33% of the company’s stock.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.